Eye treatment may lift mood: PROSE lenses tested for depression relief
NCT ID NCT07195721
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether PROSE treatment—a custom contact lens that soothes the eye surface—can also improve mental health in people with major depression. Researchers will track depression scores and eye symptoms in 200 adults over time. The goal is to see if treating severe dry eye can lift mood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PROSE treatment (a special contact lens that protects the eye surface)
- What this could lead to
- If it works, this could show that treating severe dry eye with PROSE lenses also eases depression symptoms.
- What could go wrong
- This is an early-stage trial with no control group, so results may not prove cause and effect. The effect on mood might be small or not last.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BostonSight
RECRUITINGNeedham, Massachusetts, 02494, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who returns to work after stress treatment?
- Can a Parent-Targeted program ease Kids' behavior problems when depression is in the picture?
- A Two-Year watch: can brain scans and surveys predict depression and anxiety in teens?
- Can a Three-Session therapy rival CBT for Event-Related depression?
- Your genes could hold the key to better depression treatment
- A therapy that aims to boost wellbeing, not just ease symptoms — a trial puts it to the test